Clinical trials: Microstomia

Microstomia, Scleroderma

Hyaluronidase Via LADD Scleroderma-induced Microstomia

• Completed
• Age: 19 years and older
• Early Phase 1
• Medical device

Two treatment methods, ablative carbon dioxide (CO2) laser and intradermal hyaluronidase, will be combined to maximize the beneficial potential of each.

Trial name

NCT05995626

Testing

Hyaluronidase, CO2 laser

Where

2 sites in United States

Volunteers

3 people, healthy volunteers welcome

Sponsor

University of Nebraska